BioHealth News Archive

Deals of the day: Botox maker gets $50 billion buyout offer – The Term Sheet: Fortune’s deals blogTerm Sheet

Deals of the day: Botox maker gets $50 billion buyout offer – The Term Sheet: Fortune’s deals blogTerm Sheet

Principia Biopharma Inc., a South San Francisco-based developer of small molecule drugs within the fields of autoimmune disease and oncology, has raised $50 million…

Read More
Maryland Invests in Cybersecurity Startup Luminal | CivSource

Maryland Invests in Cybersecurity Startup Luminal | CivSource

Maryland’s efforts to build out the local cybersecurity economy seem to be working. Cybersecurity startup Luminal recently announced a move to Maryland from West…

Read More
Three ways to increase your startup’s chances of getting acquired by GE Healthcare

Three ways to increase your startup’s chances of getting acquired by GE Healthcare

Cultural fit, bundling potential and a focus on work force optimization. If your healthcare startup meets all or even two of these criteria, you’ll…

Read More
Johns Hopkins makes list of wealthiest universities – Baltimore Business Journal

Johns Hopkins makes list of wealthiest universities – Baltimore Business Journal

Johns Hopkins University is among the 50 wealthiest universities across the globe. The university’s endowment value in 2013 was $2.987 billion — good for…

Read More
Seeking the Right Chemistry, Drug Makers Hunt for Mergers – NYTimes.com – NYTimes.com

Seeking the Right Chemistry, Drug Makers Hunt for Mergers – NYTimes.com – NYTimes.com

The pharmaceutical industry is regaining its swagger, as companies turn to big and sometimes daring deals to expand and reshape their operations. On Tuesday…

Read More
Cotton Rat Influenza Model Launched by Noble Life Sciences in Partnership with IBT Bioservices – Noble Life Sciences

Cotton Rat Influenza Model Launched by Noble Life Sciences in Partnership with IBT Bioservices – Noble Life Sciences

Noble Life Sciences (Gaithersburg, MD) and IBT Bioservices (Gaithersburg, MD) announce a newly optimized cotton rat model for preclinical studies of influenza therapies and…

Read More
SBIR/STTR Resubmission Frequently Asked Questions

SBIR/STTR Resubmission Frequently Asked Questions

Before April 16, 2014, NIH permitted one resubmission (A1) of an unfunded application (see NOT-OD-09-016).  The extension on the NIH grant number could follow…

Read More
GSK plc announces major three-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholders | 2014 | Press releases | Media | GlaxoSmithKline

GSK plc announces major three-part transaction with Novartis to drive sustainable sales growth, improve long-term earnings and deliver increasing returns to shareholders | 2014 | Press releases | Media | GlaxoSmithKline

GlaxoSmithKline plc today announces a major 3-part inter-conditional transaction with Novartis AG involving its Consumer Healthcare, Vaccines and Oncology businesses (the “Transaction”). In summary:…

Read More
Emergent BioSolutions and FDA Finalize Comparability Protocols Enabling Manufacturing of BioThrax Consistency Lots in Building 55 – MarketWatch

Emergent BioSolutions and FDA Finalize Comparability Protocols Enabling Manufacturing of BioThrax Consistency Lots in Building 55 – MarketWatch

Emergent BioSolutions Inc.  today announced that it has initiated manufacturing of BioThrax® (Anthrax Vaccine Adsorbed) consistency lots in Building 55, following review by the…

Read More
APX Labs raises $10M from New Enterprise Associates to push Google Glass, other wearables into the enterprise – Washington Business Journal

APX Labs raises $10M from New Enterprise Associates to push Google Glass, other wearables into the enterprise – Washington Business Journal

Herndon-based APX Labs has raised $10 million from New Enterprise Associates to bring its software platform for Google Glass and other wearables to manufacturing,…

Read More
Crowdfunding for biotechnology: Microfinancing to personal cancer fight

Crowdfunding for biotechnology: Microfinancing to personal cancer fight

The impact of federal budget cuts compounded by the challenges of securing funding for biotechnology companies has led to a growing trend of drug…

Read More
As Health IT Stays Hot, Healthbox Boosts Accelerators Program – Venture Capital Dispatch – WSJ

As Health IT Stays Hot, Healthbox Boosts Accelerators Program – Venture Capital Dispatch – WSJ

Healthbox, which helps medical startups grow through accelerators in the U.S. and U.K., is expanding its business through a $7 million fundraising. Healthbox CEO…

Read More
Pfizer to buy AstraZeneca? – Philadelphia Business Journal

Pfizer to buy AstraZeneca? – Philadelphia Business Journal

Two Big Pharma companies with strong ties to the Philadelphia region are the subject of the latest mega-merger rumor in the drug manufacturing industry.…

Read More
Vendor Night 2014 – ISPE Chesapeake Bay Chapter

Vendor Night 2014 – ISPE Chesapeake Bay Chapter

April 30, 2014 Don’t miss this unique opportunity to showcase your products and services to the mid-Atlantic region. The Universities at Shady Grove is…

Read More
Emergent BioSolutions Receives Orphan Drug Designation for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease – MarketWatch

Emergent BioSolutions Receives Orphan Drug Designation for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease – MarketWatch

Emergent BioSolutions Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BioThrax® (Anthrax Vaccine Adsorbed) for…

Read More